Internal Medicine, Clinical Cardiatric Electrophysiology · Milwaukee, WI
NPI
1962479527
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2801 W Kinnickinnic River Pkwy, Suite 777
Milwaukee, WI, 53215
Phone (414) 385-2834
Groups this clinician bills Medicare through
Medicare paid, 2024
$220K
5,292 services
Medicare patients, 2024
1,764
Average age 76
Drug cost, 2024
$2.8M
8,696 prescriptions
Company payments, 2025
$86.52
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Atul Bhatia was code 93296 (external electrocardiographic monitoring), 963 times for 529 patients. In total Atul Bhatia billed 5,292 services in 78 codes, and Medicare paid $220K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93296 External Electrocardiographic Monitoring | Office | 963 | 529 | $12.67 | $12K |
| 93010 Electrocardiogram | Facility | 800 | 520 | $5.71 | $4,565 |
| 93294 External Electrocardiographic Monitoring | Office | 547 | 281 | $17.36 | $9,497 |
| 93000 Electrocardiogram | Office | 545 | 428 | $9.70 | $5,284 |
| 93295 External Electrocardiographic Monitoring | Office | 362 | 185 | $21.44 | $7,760 |
| 99214 Office E&M - Established | Office | 307 | 254 | $84.08 | $26K |
| 99213 Office E&M - Established | Office | 211 | 203 | $60.31 | $13K |
| 93280 External Electrocardiographic Monitoring | Office | 162 | 141 | $51.72 | $8,379 |
| 93298 External Electrocardiographic Monitoring | Office | 75 | 40 | $59.31 | $4,448 |
| 99215 Office E&M - Established | Office | 63 | 59 | $122.13 | $7,694 |
| 93282 External Electrocardiographic Monitoring | Office | 63 | 53 | $50.60 | $3,188 |
| 93284 External Electrocardiographic Monitoring | Office | 60 | 50 | $67.07 | $4,024 |
| 99204 Office E&M - New | Office | 60 | 60 | $109.02 | $6,541 |
| 99222 Hospital E&M - Initial | Facility | 55 | 55 | $95.02 | $5,226 |
| 93793 Care Management/Coordination | Office | 50 | 18 | $8.53 | $427 |
By year: 2022 $238K for 6,292 services; 2023 $217K for 5,569 services; 2024 $220K for 5,292 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 39 | 13 | $4.20 | $164 |
Medicare prescription drug claims, 2024
In 2024, the drug Atul Bhatia prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,831 prescriptions and refills. In total Atul Bhatia wrote 8,696 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,831 | 3,525 | 438 | $2.0M |
| Metoprolol Succinate Generic | 1,818 | 5,017 | 559 | $27K |
| Dofetilide Generic | 626 | 1,528 | 159 | $87K |
| Flecainide Acetate Generic | 527 | 1,466 | 157 | $26K |
| Amiodarone Hcl Generic | 434 | 1,147 | 144 | $5,547 |
| Xarelto Rivaroxaban | 352 | 809 | 93 | $445K |
| Metoprolol Tartrate Generic | 271 | 775 | 92 | $2,519 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 262 | 691 | 71 | $8,313 |
| Carvedilol Generic | 255 | 733 | 88 | $2,546 |
| Sotalol Sotalol Hcl | 239 | 651 | 60 | $6,310 |
| Losartan Potassium Generic | 180 | 492 | 55 | $1,610 |
| Warfarin Sodium Generic | 167 | 450 | 53 | $1,670 |
| Lisinopril Generic | 138 | 385 | 38 | $954 |
| Mupirocin Generic | 136 | 137 | 134 | $1,025 |
| Mexiletine Hcl Generic | 113 | 261 | 30 | $14K |
Brand drugs: 2,383 claims; generic drugs: 6,313 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Atul Bhatia $86.52 ($86.52 in general payments such as food, travel and fees) from 2 companies. The largest payer was Penumbra, Inc. with $69.8.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.